NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,422.0 Cr | 2.1% | -6.7% | 16.2% | Stock Analytics | |
| ADANI ENTERPRISES | ₹235,637.0 Cr | -2.6% | -13.8% | -19.8% | Stock Analytics | |
| REDINGTON | ₹15,698.0 Cr | -3.7% | -14% | -7.7% | Stock Analytics | |
| HONASA CONSUMER | ₹9,700.9 Cr | 6.1% | -4.2% | 29.8% | Stock Analytics | |
| MMTC | ₹8,277.0 Cr | -5.7% | -7.4% | 5.4% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,498.5 Cr | -2.2% | -16.7% | 9.6% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 2.1% |
-6.7% |
16.2% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses